Ferrari-Souza, João Pedro
Bellaver, Bruna http://orcid.org/0000-0002-2212-3373
Ferreira, Pâmela C. L. http://orcid.org/0000-0003-2134-9829
Benedet, Andréa L.
Povala, Guilherme http://orcid.org/0000-0002-2023-6569
Lussier, Firoza Z.
Leffa, Douglas T.
Therriault, Joseph http://orcid.org/0000-0002-7826-4781
Tissot, Cécile http://orcid.org/0000-0003-2711-3833
Soares, Carolina http://orcid.org/0000-0002-2338-4495
Wang, Yi-Ting http://orcid.org/0000-0002-9130-5461
Chamoun, Mira
Servaes, Stijn
Macedo, Arthur C.
Vermeiren, Marie
Bezgin, Gleb
Kang, Min Su http://orcid.org/0000-0003-0745-6222
Stevenson, Jenna
Rahmouni, Nesrine
Pallen, Vanessa
Poltronetti, Nina Margherita
Cohen, Ann
Lopez, Oscar L.
Klunk, William E.
Soucy, Jean-Paul
Gauthier, Serge
Souza, Diogo O.
Triana-Baltzer, Gallen
Saad, Ziad S.
Kolb, Hartmuth C. http://orcid.org/0000-0003-2414-5792
Karikari, Thomas K. http://orcid.org/0000-0003-1422-4358
Villemagne, Victor L.
Tudorascu, Dana L.
Ashton, Nicholas J.
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Blennow, Kaj http://orcid.org/0000-0002-1890-4193
Zimmer, Eduardo R. http://orcid.org/0000-0002-5349-0053
Rosa-Neto, Pedro http://orcid.org/0000-0001-9116-1376
Pascoal, Tharick A. http://orcid.org/0000-0001-9057-8014
Article History
Received: 18 December 2022
Accepted: 16 August 2023
First Online: 25 September 2023
Competing interests
: S.G. has served as a scientific advisor to Cerveau Technologies. N.J.A. has given lectures in symposia sponsored by Lilly and Quanterix. G.T.-B., Z.S.S. and H.C.K. are employees of Janssen R&D and receive salary and stock from its parent company, Johnson & Johnson. H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Passage Bio, Pinteon Therapeutics, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen and Roche and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. K.B. has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics and Siemens Healthineers and is a co-founder of BBS, which is a part of the GU Ventures Incubator Program. E.R.Z. serves on the scientific advisory board of Next Innovative Therapeutics. The other authors declare no competing interests.